Please find the attached for In-principle approval received from BSE.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Crescentis Capital Ltd has received in-principle approval from BSE Limited for issuing up to 13,00,000 equity shares of face value ₹10 each under its 'Employees' Stock Option Scheme 2025'. The approval was granted via BSE letter dated April 02, 2026, but actual allotment will only happen when employees exercise their stock options. The approval is subject to standard conditions like SEBI ESOP regulations, payment of fees, and compliance with listing agreements. This is a regulatory clearance, not an immediate share issuance. If all options are eventually exercised, the company's share base will expand by up to 13 lakh shares.
This is a routine pre-requisite approval and does not immediately dilute shareholders. However, if employees fully exercise the 13 lakh options in the future, existing shareholders will face equity dilution and a potential increase in total share count.